We are live on ! Find out more
ICUI icon

ICU Medical

220 hedge funds and large institutions have $2.66B invested in ICU Medical in 2023 Q3 according to their latest regulatory filings, with 30 funds opening new positions, 72 increasing their positions, 80 reducing their positions, and 40 closing their positions.

New
Increased
Maintained
Reduced
Closed

8% more call options, than puts

Call options by funds: $2.88M | Put options by funds: $2.67M

0.06% less ownership

Funds ownership: 92.47%92.41% (-0.06%)

5% less funds holding

Funds holding: 231220 (-11)

10% less repeat investments, than reductions

Existing positions increased: 72 | Existing positions reduced: 80

25% less first-time investments, than exits

New positions opened: 30 | Existing positions closed: 40

33% less capital invested

Capital invested by funds: $3.96B → $2.66B (-$1.31B)

Holders
220
Holders Change
-11
Holders Change %
-4.76%
% of All Funds
3.49%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.02%
New
30
Increased
72
Reduced
80
Closed
40
Calls
$2.88M
Puts
$2.67M
Net Calls
+$215K
Net Calls Change
-$22.3M
Name Holding Trade Value Shares
Change
Change in
Stake
ZIM
226
Zacks Investment Management
Illinois
-$2.42M -13,588 Closed
State of Tennessee, Department of Treasury
227
State of Tennessee, Department of Treasury
Tennessee
-$1.91M -10,694 Closed
Squarepoint
228
Squarepoint
New York
-$1.17M -6,546 Closed
DTL
229
Dynamic Technology Lab
Singapore
-$959K -5,380 Closed
Wolverine Trading
230
Wolverine Trading
Illinois
-$832K -4,702 Closed
OCBCO
231
Oversea-Chinese Banking Corp (OCBC)
Singapore
-$657K -3,685 Closed
Susquehanna International Group
232
Susquehanna International Group
Pennsylvania
-$469K -3,143 Closed
WCM
233
Washington Capital Management
Washington
-$517K -2,900 Closed
YIH
234
Y-Intercept (HK)
Hong Kong
-$439K -2,462 Closed
NRD
235
Nebula Research & Development
New York
-$425K -2,386 Closed
VPIM
236
Vanguard Personalized Indexing Management
California
-$333K -1,869 Closed
CSS
237
Cubist Systematic Strategies
Connecticut
-$329K -1,849 Closed
VF
238
Virtu Financial
New York
-$321K -1,802 Closed
Mercer Global Advisors
239
Mercer Global Advisors
Colorado
-$306K -1,719 Closed
CGH
240
Crossmark Global Holdings
Texas
-$292K -1,639 Closed
Prudential Financial
241
Prudential Financial
New Jersey
-$289K -1,623 Closed
MSRPS
242
Maryland State Retirement & Pension System
Maryland
-$277K -1,553 Closed
Teacher Retirement System of Texas
243
Teacher Retirement System of Texas
Texas
-$275K -1,546 Closed
SG Americas Securities
244
SG Americas Securities
New York
-$251K -1,406 Closed
VT
245
Vise Technologies
New York
-$234K -1,315 Closed
Truist Financial
246
Truist Financial
North Carolina
-$225K -1,265 Closed
ProShare Advisors
247
ProShare Advisors
Maryland
-$219K -1,228 Closed
BF
248
BOK Financial
Oklahoma
-$41K -230 Closed
PI
249
PineBridge Investments
New York
-$38.7K -217 Closed
FGAM
250
Financial Gravity Asset Management
Texas
-$251 -178 Closed

ICUI Hedge Fund Activity: Q3 2023 in Review

220 of the 6,301 institutional investors tracked by Wall St. Rank reported a position in ICU Medical (ICUI) for Q3 2023, worth a combined $2.66B — down 33% from $3.96B a quarter earlier.

Sellers outnumbered buyers: 40 funds closed out of ICUI and 30 opened new positions — a net loss of 10 holders — while 80 trimmed existing stakes and 72 added.

The largest buyer was Fidelity Investments, adding an estimated $79.5M. The largest seller was Wellington Management Group, cutting an estimated $61.6M.

  • 220 institutional investors held ICU Medical (ICUI) as of Q3 2023, down from 231 in Q2 2023.
  • Funds reported $2.66B of ICU Medical stock for Q3 2023, down 33% quarter-over-quarter.
  • 30 funds opened new ICU Medical positions in Q3 2023 and 40 closed out, a net change of -10 holders.
  • The largest ICU Medical buyer in Q3 2023 was Fidelity Investments, an estimated $79.5M added.
  • The largest ICU Medical seller in Q3 2023 was Wellington Management Group, an estimated $61.6M sold.

Based on aggregated 13F filings for Q3 2023.